Autres langues Kaken Pharmaceutical Co., Ltd.

Actions

4521

JP3207000005

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
3 478 ^JPY	+0,03%		+2,08%	+3,67%

2023	Kaken Pharmaceutical Co. fournit des prévisions financières consolidées pour l'année fiscale se terminant le 31 mars 2024	CI
2023	Le bénéfice attribuable de Kaken Pharmaceutical chute de 13,7 % au premier trimestre fiscal en raison de dépenses plus élevées	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Kaken Pharmaceutical Co., Ltd. Declares Dividend for the Second Quarter of Fiscal Ending March 2024, Payable on November 30, 2023; Provides Dividend Guidance for the Full Year Ending March 31, 2024	14/11
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for Fiscal Year Ending March 31, 2024	14/11
Kaken Pharmaceutical : Presentation material for meeting	09/11
Kaken Pharmaceutical : Reference Data of Financial Statements for the 2Q of Fiscal 2023	08/11
Kaken Pharmaceutical : Corporate Report 2023	01/11
Kaken Pharmaceutical Co., Ltd.(TSE:4521) dropped from FTSE All-World Index	18/09/23
Kaken Pharmaceutical’s Attributable Profit Drops 13.7% in Fiscal Q1 due to Higher Expenses	18/08/23
Kaken Pharmaceutical Co., Ltd. Provides Dividend Forecast for Second Quarter of 2024 and Fiscal Year Ending March 31, 2024	17/08/23
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for Fiscal Year Ending March 31, 2024	17/08/23
Kaken Pharmaceutical : Reference Data of Consolidated Financial Results for 1st Quarter of Fiscal 2023	04/08/23
MediWound Announces Commercial Launch of NexoBrid in Japan	02/08/23
MediWound Partner Launches NexoBrid in Japan	01/08/23
Botanix Pharmaceuticals Partner Secures Sublicense, Distribution Deal in Korea	05/06/23
Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program	16/05/23
Kaken Pharmaceutical : Presentation material for meeting	11/05/23
Kaken Pharmaceutical : Reference Data of Financial Statements Fiscal 2022	10/05/23
Kaken Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	10/05/23
Kaken Pharmaceutical : Consolidated Financial Results for the Fiscal 2022	10/05/23
Kaken Pharmaceutical : Reference Data of Financial Statements for the 3Q of Fiscal 2022	03/02/23
Kaken Pharmaceutical : Consolidated Financial Results for the Third Quarter of Fiscal 2022	03/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kaken Pharmaceutical Co., Ltd.

Actions

4521

JP3207000005

Autres langues

Filtres